Heidelberg, Germany

Martin Volkmann

This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Volkmann. Retrieved from https://idiyas.com/inventor/martin-volkmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Volkmann: Innovator in Cancer Research

Introduction

Martin Volkmann is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer research, particularly through his innovative methods for detecting specific antibodies.

Latest Patents

Volkmann holds a patent for a "Method of detecting p53-specific antibodies." This invention is crucial for advancing cancer diagnostics and improving patient outcomes.

Career Highlights

He is currently affiliated with the Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts, where he continues to work on groundbreaking research in oncology. His dedication to cancer research has positioned him as a key figure in the scientific community.

Collaborations

Throughout his career, Volkmann has collaborated with esteemed colleagues such as Hanswalter Zentgraf and Peter Schranz. These partnerships have further enhanced the impact of his research.

Conclusion

Martin Volkmann's contributions to cancer research through his innovative patent and collaborations highlight his commitment to improving healthcare. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…